Abpro Holdings Inc.
10/02/2025 | Press release | Distributed by Public on 10/02/2025 14:15
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 30, 2025, Abpro Holdings, Inc. (the "Company") furloughed Robert J. Markelewicz, Jr., M.D., M.M.Sc., the Company's Chief Medical Officer, effective September 30, 2025 until November 30, 2025. During the furlough period, Dr. Markelewicz will not perform any duties or responsibilities associated with his role. Dr. Markelewicz's employment will be terminated effective November 30, 2025.
Abpro Holdings Inc. published this content on October 02, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 02, 2025 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]